These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32675393)

  • 21. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
    Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
    Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
    J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
    Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
    Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
    Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
    Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
    Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z
    Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
    Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
    Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA H19 may be a marker for prediction of prognosis in the follow-up of patients with papillary thyroid cancer.
    Jiao X; Lu J; Huang Y; Zhang J; Zhang H; Zhang K
    Cancer Biomark; 2019; 26(2):203-207. PubMed ID: 31403942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
    Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
    Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
    Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
    OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
    Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
    Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma.
    Shen Y; Xia E; Bhandari A; Wang X; Guo G
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
    He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
    Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.
    Wu S; Zhu J; Jiang T; Cui T; Zuo Q; Zheng G; Li G; Zhou J; Chen X
    Clin Epigenetics; 2024 Jan; 16(1):10. PubMed ID: 38195623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of DANCR acts as a potential biomarker for papillary thyroid cancer diagnosis.
    Zhang K; Lv J; Peng X; Liu J; Li C; Li J; Yin N; Li H; Li Z
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations of ultrasound and pathological features of thyroid carcinoma with TC-1 mRNA and protein expression.
    Zhang CL; Geng CH; Jian JJ; He M; Zhao HW; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3440-3446. PubMed ID: 31081098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.
    Qi T; Rong X; Feng Q; Sun H; Cao H; Yang Y; Feng H; Zhu L; Wang L; Du Q
    Int J Med Sci; 2021; 18(12):2532-2544. PubMed ID: 34104084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.